Helping patients reclaim a life of possibility
To mark World Blood Cancer Day on 28 May, we are highlighting the important work of our Polish member, the Carita Foundation and how they have collaborated with us to raise awareness of important issues with Polish policymakers. The Carita Foundation has today participated in a meeting of the Parliamentary Working Group on Oncology in the Polish Parliament. This meeting…
Bosnia and Herzegovina marks myeloma awareness month We are delighted to share an update from our member organisation in Bosnia and Herzegovina, who marked Myeloma Action Month with a series of meaningful activities in March. On 26 March, they organised a professional meeting in Tuzla, bringing together over 50 participants including haematologists, healthcare professionals, patients…
At the MPE Annual General Meeting on Tuesday, 31 March, we were pleased to welcome four new member organisations into the MPE community and to confirm the results of our board elections. Together, they represent the continued growth and diversity of the myeloma and amyloidosis patient community across Europe. New members Hellenic Multiple Myeloma Patient…
Myeloma Patients Europe (MPE) will hold a webinar on the generics market in Europe and implications for cancer treatment and care on Monday 30th March from 17:00 – 18:30 CET. A generic medicine has the same active ingredient as a branded medicine and can be produced after the patent for the branded medicine expires. For…
More than 65 per cent of people living with an oncohaematological disease experience a deterioration in their employment and financial situation. This is one of the key findings of a report developed and presented by AELCLÉS, one of the Spanish members of Myeloma Patients Europe (MPE). According to the report, over 65 per cent of…
On 13–14 December in Warsaw, the Carita Foundation hosted its Hemato-Oncology Patient Forum, bringing together 150 participants including patients, clinicians, pharmaceutical representatives and volunteers. The event marked the 15th anniversary of the Carita Foundation and the 35th anniversary of the International Myeloma Foundation (IMF), which co-organised the Forum alongside MPE. The programme featured international experts and…
The largest haematology meeting in the world has just finished. The American Society of Hematology (ASH) Annual Congress took place in Orlando, Florida, US, where the latest research in blood diseases was presented. Myeloma Patients Europe (MPE) interviewed key experts to learn more about the most relevant studies and abstracts in myeloma and AL amyloidosis.…
From 6-9 December Myeloma Patients Europe (MPE) attended the American Society of Hematology (ASH) Annual Meeting in Orlando, Florida. Over 20,000 researchers, doctors, nurses and patient advocates attended the meeting to share and discuss the results of the latest research from across blood cancers. ASH was a great way to close out another successful year…